Divergence, Inc. is a biotechnology company focused on reducing the
impact of parasitic nematode worms, devastating unseen pests
that cause billions of dollars in crop losses annually and substantial morbidity to people, livestock,
Sustainable food production and improved human health depends upon innovation in biotechnology.
We apply innovation to the control of parasitic nematode worms in plants and in human and veterinary
medicine. For example, Divergence is developing the first novel modes of action in decades for the plant
nematode control market. The privately held company operates from laboratories at the
Bio-Research & Development Growth (BRDG) Park in St. Louis, Missouri and collaborates with leading companies
in plant biotechnology and animal health.